Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Sethi

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.
Oncotarget|April 21, 2015
miR-20b is up-regulated in brain metastases from primary breast cancersAamir Ahmad, Kevin R Ginnebaugh, Seema Sethi, et al.
International Journal of Cancer|September 9, 2010
Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivoSanjeev Banerjee, Dejuan Kong, Asfar S Azmi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"Se-Hoon Lee, Shun Lu, James Chih-Hsin Yang, et al.
Cancer Research|March 11, 2011
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cellsAamir Ahmad, Amro Aboukameel, Dejuan Kong, et al.
Molecular Cancer Therapeutics|March 1, 2013
Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancerShuping Yin, Liping Xu, R Daniel Bonfil, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 12, 2015
Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cellsKatharina Mahal, Aamir Ahmad, Seema Sethi, et al.
Neoplasia (New York, N.Y.)|May 3, 2011
p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancerFanyan Meng, Haijun Zhang, Gang Liu, et al.
Cancer Research|July 14, 2011
Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signalingHaijun Zhang, Fanyan Meng, Sherwin Wu, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 19, 2006
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinomaMaria J Worsham, Kang Mei Chen, Nivedita Tiwari, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Anticancer Research|July 31, 2012
Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinomaKhaldoun Almhanna, Bassel El-Rayes, Seema Sethi, et al.
Oncotarget|April 21, 2015
miR-20b is up-regulated in brain metastases from primary breast cancersAamir Ahmad, Kevin R Ginnebaugh, Seema Sethi, et al.
International Journal of Cancer|September 9, 2010
Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivoSanjeev Banerjee, Dejuan Kong, Asfar S Azmi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"Se-Hoon Lee, Shun Lu, James Chih-Hsin Yang, et al.
Cancer Research|March 11, 2011
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cellsAamir Ahmad, Amro Aboukameel, Dejuan Kong, et al.
Molecular Cancer Therapeutics|March 1, 2013
Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancerShuping Yin, Liping Xu, R Daniel Bonfil, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 12, 2015
Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cellsKatharina Mahal, Aamir Ahmad, Seema Sethi, et al.
Neoplasia (New York, N.Y.)|May 3, 2011
p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancerFanyan Meng, Haijun Zhang, Gang Liu, et al.
Cancer Research|July 14, 2011
Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signalingHaijun Zhang, Fanyan Meng, Sherwin Wu, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 19, 2006
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinomaMaria J Worsham, Kang Mei Chen, Nivedita Tiwari, et al.
Pageof 8